Mary Meaney

About Mary

Mary serves on McKinsey’s Shareholders Council, the global governance board, where she sits on both the people committee and M&A committee. She coleads the Organization Practice globally and is the co-author of Leading Organizations: Ten Timeless Truths.

For more than 20 years she has served leading pharma, consumer products, energy, basic materials, telecommunications, and public sector organizations on their most important transformation, change management, top-team alignment, and performance improvement efforts.

Mary works with a broad range of clients in all sectors on performance and organizational health issues, applying her deep understanding of change management and organizational transformations. She primarily advises clients in the consumer packaged goods, chemical, and pharmaceutical industries, as well as the public sector. She is also active in other sectors including energy, basic materials, mining, high-tech, and private equity.

She is a cofounder of the McKinsey Women’s Initiative—in Europe, the Middle East, and Africa—Women as Leaders program, and Remarkable Women Program, all which aim to promote women leaders in business. In this context, she regularly participates in McKinsey research evaluating the progress of women in leadership in the corporate world and recommending means of fostering it. Her research work on leadership also addresses the behavioral dynamics in operational and management teams.

A Rhodes scholar, Mary began her career in McKinsey at the Washington DC office, and then spent 13 years in the London office. She moved to Paris in 2011.

In addition to her consulting work, Mary sits on the advisory board of Imperial Business School and was previously on the board of TeachFirst. She graduated summa cum laude with a BA in public and international affairs from Princeton University. She won the Rhodes scholarships and earned a PhD in politics from the University of Oxford.

She is also a member of the business development committee of Philharmonia Orchestra.